Merck completes $2.7bn Acquisition Of Biopharmaceutical Firm ArQule

▴ Merck completes 27bn Acquisition Of Biopharmaceutical Firm ArQule
ArQule now operates as a wholly-owned subsidiary of Merck, as the deal concluded.ArQule is primarily focused on the research and development of targeted therapeutics for the treatment of cancers and rare diseases.

Merck has completed the acquisition of US-based biopharmaceutical company ArQule in a deal valued at around $2.7bn via its subsidiary, Merck has completed the cash tender offer to acquire all the outstanding shares of ArQule at a purchase price of $20 per share.

Merck said that the 103,394,298 shares of common stock of ArQule have been validly tendered and not withdrawn from the tender offer, representing around 75.3% of the outstanding common stock of ArQule on a fully diluted basis.In December 2019, Merck, through its subsidiary, commenced a cash tender offer to acquire all outstanding shares of common stock of ArQule.Merck has concluded the acquisition of ArQule through a merger of its wholly-owned subsidiary, following the completion of the tender offer.

ArQule now operates as a wholly-owned subsidiary of Merck, as the deal concluded.ArQule is primarily focused on the research and development of targeted therapeutics for the treatment of cancers and rare diseases.

The company aims to discover, develop and commercialise novel small molecule drugs in areas of high unmet need.

Tags : #Merck #Acquires #Arqule #27billion

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

US has biggest COVID-19 testing programmeJuly 14, 2020
NHPC organizes blood donation camp to support blood banks July 14, 2020
Studies predicts surge in HIV, TB, and Malaria deaths due to COVID-19July 14, 2020
AIIMS Patna starts human trial of Coronavirus vaccineJuly 14, 2020
World’s population likely to shrink after mid-century : LancetJuly 14, 2020
21 deaths, 1,654 fresh Covid-19 cases in UP; total count 38,130July 14, 2020
Over 90 doctors have died so far IMAJuly 14, 2020
Glenmark cuts price of Covid-19 drug Favipiravir version to $1 per tabJuly 14, 2020
19 States, UTs report higher recovery rate than national average of 63%July 14, 2020
Govt advises cautious use of Remdesivir, Tocilizumab for Covid-19 July 13, 2020
Govt in process of selecting 3 bulk drug and 4 medical devices parkJuly 13, 2020
Glenmark commences 1000 patients surveillance study ; FabiFluJuly 13, 2020
Neuherbs enters in sanitation category, launches sub-brand NeusafeJuly 13, 2020
Thailand gears up for human trials for their COVID-19 vaccineJuly 13, 2020
How the world's busiest airport envisions travel amid COVID-19July 13, 2020
Mexico coronavirus death count risesJuly 13, 2020
Florida sets 1-day record of new COVID-19 casesJuly 13, 2020
Russian University claims successful trials of 1st COVID-19 vaccineJuly 13, 2020
Over 5,53000 recovered so far: COVID recovery rate reaches 63.01%July 13, 2020
Bihar reports largest ever spike with 1266 COVID cases in last 24 hrsJuly 13, 2020